714
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals

, , &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

Andreas Schneider, Philipp Richard, Philippe Mueller, Christoph Jordi, Mary Yovanoff & Jakob Lange. (2021) User-Centric Approach to Specifying Technical Attributes of Drug Delivery Devices: Empirical Study of Autoinjector-Cap Removal Forces. Patient Preference and Adherence 15, pages 159-168.
Read now
Meghan E Pauley, Cari Berget, Laurel H Messer & Gregory P Forlenza. (2021) Barriers to Uptake of Insulin Technologies and Novel Solutions. Medical Devices: Evidence and Research 14, pages 339-354.
Read now
Xavier Chalhoub, Sara Marchner-Palmer & Ali Ghanem. (2020) Motorized botulinum toxin injection device: a pilot study on attitudes toward technology-assisted injection in novice and experienced cosmetic practitioners. Journal of Cosmetic and Laser Therapy 22:4-5, pages 200-204.
Read now
Mark L. Warren, Meryl Brod, Jonas Håkan-Bloch, Thomas Sparre & Louis B. Chaykin. (2019) Patient-reported outcomes from a randomized, crossover trial comparing a pen injector with insulin degludec versus a pen injector with insulin glargine U100 in patients with type 2 diabetes. Current Medical Research and Opinion 35:9, pages 1623-1629.
Read now
Andreas Schneider, Harald Kolrep, Christoph Jordi, Philipp Richard, Hanns-Peter Horn & Jakob Lange. (2019) How to prevent medication errors: a multidimensional scaling study to investigate the distinguishability between self-injection platform device variants. Expert Opinion on Drug Delivery 16:8, pages 883-894.
Read now
Quentin Lohmeyer, Andreas Schneider, Christoph Jordi, Jakob Lange & Mirko Meboldt. (2019) Toward a new age of patient centricity? The application of eye-tracking to the development of connected self-injection systems. Expert Opinion on Drug Delivery 16:2, pages 163-175.
Read now
Joan Schertz & Hilary Worton. (2018) Nurse evaluation of the redesigned fertility pen injector: a questionnaire-based observational survey. Expert Opinion on Drug Delivery 15:5, pages 435-442.
Read now
Andreas E. Schneider & Jakob Lange. (2018) Pen devices for self-injection: contrasting measured injection force with users’ perceived ease of injection. Expert Opinion on Drug Delivery 15:2, pages 115-125.
Read now
Timothy S. Reid, Fryn Schafer & Cynthia Brusko. (2017) Higher concentration insulins: an overview of clinical considerations. Postgraduate Medicine 129:5, pages 554-562.
Read now
Barbara Domańska, Brenda VanLunen, Luke Peterson, Irina Mountian & Michael Schiff. (2017) Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis. Expert Opinion on Drug Delivery 14:1, pages 15-22.
Read now

Articles from other publishers (6)

Małgorzata Masierek, Katarzyna Nabrdalik, Oliwia Janota, Hanna Kwiendacz, Maksymilian Macherski & Janusz Gumprecht. (2022) The Review of Insulin Pens—Past, Present, and Look to the Future. Frontiers in Endocrinology 13.
Crossref
Vincent Woo, Lori Berard & Robert Roscoe. (2020) Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review. Diabetes Therapy 11:11, pages 2539-2553.
Crossref
Arvind GuptaSanjeev PhatakY. Sadashiv RaoJayanthy Ramesh & Debmalya Sanyal. (2020) Consensus on Choice of Insulin Pen Devices in Routine Clinical Practice in India. Diabetes Technology & Therapeutics 22:10, pages 777-786.
Crossref
Sudesna Chatterjee, Kamlesh Khunti & Melanie J. Davies. (2019) Achieving Glycaemic Control with Concentrated Insulin in Patients with Type 2 Diabetes. Drugs 79:2, pages 173-186.
Crossref
Niels GudiksenThibaud HofstätterBirgitte B. RønnThomas Sparre. (2017) FlexTouch: An Insulin Pen-Injector with a Low Activation Force Across Different Insulin Formulations, Needle Technologies, and Temperature Conditions. Diabetes Technology & Therapeutics 19:10, pages 603-607.
Crossref
Judy Crespi Lofton. (2017) Beyond oral antidiabetics: Insulin therapy options and combinations. Pharmacy Today 23:6, pages 53-65.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.